肝硬化患者急性肾脏病的自然史
该研究纳入272例连续就诊的肝硬化门诊患者,评估急性肾脏病(AKD)的患病率及其对临床病程和生存的影响。随访期间80例(29.4%)发生AKD,AKD患者5年生存率显著低于无AKD者(34.8% vs. 88.8%,p<0.001),且肝硬化并发症和住院率更高。AKD可逆转、可复发并可进展为慢性肾脏病(CKD)。
要点
- 肝硬化患者中AKD发生率为29.4%(80/272)。
- AKD患者5年生存率显著低于无AKD者(34.8% vs. 88.8%,p<0.001)。
- AKD可逆转、可复发,并可进展为CKD。
核心结论
- AKD在肝硬化患者中常见,可逆转但可复发并进展为CKD,对发病率和死亡率有非常负面的影响。
研究设计与样本
- 研究纳入272例连续就诊于门诊的肝硬化患者,收集入组时临床和实验室数据,随访至死亡、肝移植或随访结束。
主要发现
- 随访期间80例(29.4%)发生AKD,其中42例(52.5%)首次AKD发作后恢复,26例维持正常肾功能至随访结束,16例发生第二次AKD发作。
- 36例(45.0%)死于AKD,11例(13.8%)AKD进展为CKD。
- AKD患者5年生存率显著低于无AKD者(34.8% vs. 88.8%,p<0.001)。
- AKD患者5年肝硬化并发症发生率和住院率均高于无AKD者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: In 2012, the KDIGO group proposed new definitions for acute kidney injury (AKI), acute kidney disease (AKD) and chronic kidney disease (CKD). According to the definition adapted by the International Club of Ascites, AKI has been extensively investigated in patients with cirrhosis. On the contrary, there are currently no data on the epidemiology and clinical outcomes associated with AKD. The aim of the study was to assess the prevalence and the impact of AKD on the clinical course and survival of patients with cirrhosis. METHODS: A total of 272 consecutive patients with cirrhosis attending our outpatient clinic were included in the study. Clinical and laboratory data were collected at inclusion. Patients were followed-up until death, liver transplant or the end of follow-up. RESULTS: During follow-up, 80 patients developed AKD (29.4%). Forty-two (52.5%) recovered from the first episode of AKD and 26 maintained a normal renal function up to the end of follow-up. Sixteen patients developed a second episode of AKD. Globally, 36 patients (45.0%) died with AKD. Finally, AKD progressed to CKD in 11 patients (13.8%). The 5-year survival rate was significantly lower in patients who developed AKD than in those who did not (34.8% vs. 88.8%, p <0.001). The 5-year rates of complications of cirrhosis and of hospitalizations were also higher in patients with AKD than in those without AKD. CONCLUSIONS: AKD is frequent in patients with cirrhosis. It can be reversible, but it may recur and progress to CKD. AKD has a very negative impact on morbidity and mortality in patients with cirrhosis. LAY SUMMARY: Renal impairment has a very negative impact on patients with cirrhosis. Renal impairment seems to be characterized by a very dynamic course, which is defined according to renal function and length of the impairment as acute kidney injury, acute kidney disease and chronic kidney disease. The role of acute kidney disease is currently unknown. Our study shows for the first time that acute kidney disease is frequent in patients with cirrhosis and has a very negative impact on survival.
引用
- Tonon M, Rosi S, Gambino CG, et al. Natural history of acute kidney disease in patients with cirrhosis. J Hepatol. 2020. PMID: 32918956. doi:10.1016/j.jhep.2020.08.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。